Tech Mahindra, Reagene to file patent for coronavirus attacking molecule

IT company Tech Mahindra is in the process of filing a patent, along with Reagene Biosciences, for a drug molecule that can potentially attack coronavirus, according to a senior company official.

Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told PTI that the company along with its partner is applying for patenting on which further testing will be done.

Markers Lab is the research and development arm of Tech Mahindra.

“We have found a molecule that can potentially attack coronavirus. We have applied for a joint patent and cannot reveal the name of the molecule unless the patent process is completed,” Malhotra said.